Thursday broker round-up
19th Jan 2017 16:45
(ShareCast News) - G4S: Barclays upgrades to equal-weight with a target price of 260p. Weir: Credit Suisse reiterates outperform, 2200p target. Coca Cola HBC: Goldman Sachs upgrades to buy with a 2120p target. Diageo: HSBC reiterates buy with a 2600p target. Aveva: Goldman Sachs reiterates sell w
Read moreSmith & Nephew confirms CFO departure, shares hit by read-across
12th Jan 2017 15:45
(ShareCast News) - Smith & Nephew confirmed that chief financial officer Julie Brown left the company earlier in the week, with shares in the company were hit by read across by US rivals and wider healthcare falls. The global medical technology business said that Brown ceased to be a director of th
Read moreSmith & Nephew appoints Graham Baker as CFO
30th Nov 2016 07:38
(ShareCast News) - Medical devices group Smith & Nephew has appointed Graham Baker as chief financial officer with effect from 1 March 2017. Baker joins the company from generic pharmaceuticals firm Alvogen, where he is currently CFO. Prior to that, he worked for AstraZeneca for 20 years, holding va
Read moreFriday broker round-up
25th Nov 2016 17:30
(ShareCast News) - Essentra: Jefferies keeps at buy with a target price of 445p. Rio Tinto: HBSC stays at buy 3300p target. Legal & General: Berenberg reiterates buy with a 301p target. Jardine Lloyd Thomson: HSBC reiterates buy with a 1100p target. Diageo: Credit Suisse keeps at outperform with
Read moreTuesday broker round-up
22nd Nov 2016 09:56
(ShareCast News) - BT Group: UBS reiterates neutral with a target price of 400p. Tesco: JP Morgan reiterates underweight with a 135p target. Relx: Credit Suisse stays at outperform with a 1600p target. Pets at Home: HSBC reiterates buy with a 320p target. Royal Dutch Shell B: UBS starts coverage
Read moreFriday broker round-up
4th Nov 2016 11:02
(ShareCast News) - Coca Cola HBC: Barclays keeps at underweight with a target price of 1630p. Smith & Nephew: Jefferies stays at buy, 1395p target. Merlin Entertainments: Berenberg starts coverage with a 440p target. South 32: Barclays reiterates overweight with a 200p target. Ladbrokes: UBS keep
Read moreSmith & Nephew third-quarter revenue up 2%
3rd Nov 2016 11:11
(ShareCast News) - Medical devices group Smith & Nephew, which makes artificial hips and knees, posted a rise in third-quarter revenue thanks to solid performances in the sports medicine joint repair and knee implants divisions. Third-quarter revenue was up 2% on an underlying basis and 1% on a repo
Read moreFTSE 100 movers: Shire and Next sold off ahead of results
31st Oct 2016 14:23
(ShareCast News) - The FTSE 100 was traipsing lower on Monday afternoon, led down by an assortment of companies across sectors, notably those that are due to report in the coming few days. Shire, which is scheduled to post its third-quarter results on Tuesday, was bottom of the pile as the drug deve
Read moreSector movers: Defensive issues reel as bond yields back-up
6th Oct 2016 19:13
(ShareCast News) - Cyclicals gained while defensive issues fell back in an overall down market ahead of the release of September´s US non-farm payrolls report the next day. Acting as a backdrop, developed world sovereign bonds dropped to their lowest levels since July as traders continued to react t
Read moreSmith & Nephew shares fall on Berenberg downgrade
6th Oct 2016 13:14
(ShareCast News) - Smith & Nephew's shares fell on Thursday as Berenberg downgraded the stock to 'hold' from 'buy' and cut the target price to 13.40p from 14.85p. "Smith & Nephew has gradually de-emphasised its slower growth areas and implemented various cost-savings measures, reinvesting the procee
Read moreWednesday broker round-up
31st Aug 2016 16:34
(ShareCast News) - Halma: Jefferies reiterates buy with a target price of 1210p. G4S: UBS maintains buy with a 260p target. Bunzl: Barclays reiterates equal-weight with a 2450p target. Carclo: Finncap reiterates hold with a 150p target. Associated British Foods: Berenberg downgrades to hold with
Read moreSmith & Nephew hit by Barclays downgrade
10th Aug 2016 10:15
(ShareCast News) - Barclays downgraded Smith & Nephew to an 'equalweight' rating from 'overweight' because of recent disappointing results, risks from competitors and likely delays to earnings-enhancing initiatives. Although it upped its price target very slightly to 1,240p from 1,230p, Barclays sai
Read moreTuesday newspaper share tips: Smith & Nephew, Meggitt
9th Aug 2016 12:46
(ShareCast News) - Smith&Nephew offers investors exposure to good market positions, especially in the emergng markets space, and a way to tap into the company´s successful acquistion track record, The Times´s Tempus says. To take note of, the business is always facing one headwind or another - be it
Read moreSmith & Nephew divests gynaecology, announces share buyback
8th Aug 2016 07:23
(ShareCast News) - Global medical technology business Smith & Nephew announced on Monday that it has completed the divestiture of its gynaecology business to Medtronic, for $350m. The FTSE 100 firm said the sale of its gynaecology business demonstrates its "disciplined strategic approach" to capital
Read moreSector movers: Oil-related sectors retreat as Aerospace & Defence flies
28th Jul 2016 16:42
(ShareCast News) - FTSE indices were mixed heading towards the closing bell on Thursday, with the blue-chip index helped south by oil stocks undermined by crude's weakness and Royal Dutch Shell's second-quarter shocker. "An unsurprisingly indecisive session in Europe has seen the likes of the FTSE l
Read more